Mineral Status in Children with End Stage Renal Failure

Lucas R.C. On a form of late rickets associated with albuminuria, rickets of adolescents. Lancet 1883; 1: 933.

Chesney R.W. Metabolic Bone Disease. Pediatr in Review 1984; 5: 227–237.

DeLuca H.F. The vitamin D system in the regulation of calcium and phosphorus metabolism. WO Atwater Memorial Lecture. Nutr Rev 1979; 37: 161.

DeLuca H.F. , Schnoes H.K. Vitamin D: Recent Advances. Ann Rev Biochem 1983; 52: 411–439.

Chesney R.W. , Hamstra A.J. , Mazess R.B. , Rose P. , DeLuca H.F. Circulating vitamin D metabolite concentrations in childhood renal diseases. Kidney Int 1982; 21: 65–69.

Portale A.A. , Booth B.E. , Tsai H.C. , Morris RC Jr. Reduced plasma concentration of 1,25-dihydroxyvitamin D in children with moderate renal insufficiency. kidney Int 1982; 21: 627–632.

Norman M.E. , Taylor A. Interrelationship of serum 25(OH)(D₃ and 1,25(OH)₂D₃ levels in juvenile renal osteodystrophy during therapy with 25(OH)₃D. Calc Tissue Int 1981; 33: 340A.

Dabbagh S. , Chesney R.W. treatment of renal osteodystrophy during childhood, in Treatment of End-stage renal Disease in Children, edited by Fine RN , and Gruskin A. , WB Saunders, Philadelphia 1984, 1984, pp 251–270.

Mehls O. , Ritz E. , Krempien B. , Gilli G. , Link K. , Willich E. , Scharer K. Slipped epiphyses in renal osteodystrophy. Arch Dis Child 1975; 50: 545.

Chesney R.W. , Avioli L.V. Childhood Renal Osteodystrophy in Edelmann C.M. Jr. , Pediatric Kidney Disease, 2nd Edition, Little, Brown and Co, Boston in press.

Hodson E.M. , Shaw P.F. , Evans R.A. Growth retardation and renal osteodystropy in children with chronic renal failure. J Pediatr 1983; 103: 735–740.

Chesney R.W. , Mazess R.B. , Rose P. , Jax D.K. Bne mineral status measured by direct photon absorptiometry in childhood renal disease. Pediatrics 1977; 60: 864.

Chesney R.W. Treatment of calcium and phosphorus abnormalities in childhood renal osteodystrophy. Dialysis & Transplant 1983; 12: 270–279.

Lopez S. , Galceran T. , Chan W. , Rapp N. , Martin K. , Slatopolsky E. Hypocalcemia may not be the cause of the development of secondary hyperparathyroidism. The American Society of Nephrology, 17th Annual Meeting, December, 1984.

Slatopolsky E. , Caglar S. , Gradowska L. , Canterbury J.M. , Reiss E. , Bricker N.S. On the prevention os secondary hyperparathyroidism in experimental chronic renal disease using “proportional reduction” of dietary phosphorus intake. Kidney Int 1972; 2: 147.

Maschio G. , Tessitore N. , D'Angelo A. Early dietary phosphorus restriction and calcium supplementatiobn in the prevention of renal osteodystrophy. Am J Clin Nutrit 1980; 33: 1546.

Llach F. , Massry S.G. , Koffler A. secondary hyperparathyroidism in early renal failure: Role of phosphate retention. Kidney Int 1977; 12: 459.

Portale A.A. , Boothe B.E. , Halloran B.P. , Morris RC Jr. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 1984; 73: 1580–1589.

Chesney R.W. , Hamstra Aj , Phelps M. , DeLuca H.F. Vitamin D metabolites in renal insufficiency and other vitamin D disorders of children. Kidney Int 1983; 24(Supp 15): 563–569.

Chesney R.W. , DeLuca H.F. , Dabbagh S. , Mahan J. , Kim Y.K. Vitamin D metabolism in longstanding nephrotic syndrome and chronic renal insufficiency. Paediatric Nephrology, ed. by Brodehl , and Ehrich J.H.H. , 1983; Springer-Verlag.

Evans R.A. , Hills E. , Wong S.Y.P. , Dunstan C.R. , Norman A.W. The use of 24,25-dihydroxycholecalciferol alone and in combination with 1,25-dihydroxycholecalciferol in chronic renal failure. In: Vitamin D Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism. Berlin, Walter de Gruyter & Co, 1982, p. 835.

Lambert P.W. , Stern P.H. , Avioli R.C. Evidence for extrarenal production of 1α,25-dihydroxyvitamin D in man. J Clin Invest 1982; 69: 722–725.

Wills M.R. , Savory J. Aluminium poisoning. Dialysis encephalopathy, osteomalacia and anaemia. Lancet 1983; 1: 29–33.

Alfrey A.C. , Le Gendre G.R. , Kaehney W.D. the dialysis encephalopathy syndrome: Posible aluminum intoxication. N Engl J Med 1976; 294: 184.

Baluarte H.J. , Gruskin A.B. , Hiner L.B. , Foley C.M. , Grover W.D. Encephalopathy in children with chronic renal failure. Proc Clin Dial Transplant Forum 1977; 7: 95.

Griswold W.R. , Reznik V. , Mendoza S.A. , Trauner D. , Alfrey A.C. Accumulation of aluminum in a nondialyzed uremic child receiving aluminum hydroxide. Pediatr 1983; 71: 56–58.

Andreoli S. , Bergstein J.M. , Sherrard D.J. Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis. N engl J Med 1984; 310: 1079–1084.

Sedman A.B. , Miller N.L. , Warady B.A. , Lum G.M. , Alfrey A.C. Aluminum loading in children with chronic renal failure. Kidney Int 1984 26: 201–204.

Hodsman A.B. , Sherrard D.J. , Alfrey A.C. Bone aluminum and histomorphometric features of renal osteodystrophy. J Clin Endocrinol Metab 1982; 54: 539.

Brown D.J. , Ham K.N. , Dawborn J.K. , Xeipell J.E. Treatment of dialysis osteomalacia with deferrioxamine. Lancet 1982; 1: 343–345.

Salusky I. Personal communication.

Brickman A.S. , Coburn J.W. , Norman A.W. Action of 1,25-dihydroxycholecalciferol, a potent, kidneyproduced metabolite of vitamin D₃, in uremic man. N Engl J Med 1972; 287: 891.

Massry S.G. Requirements of vitamin D metabolites in patients with renal disease. Am J Clin Nutr 1980; 33: 1530.

Baron R. , Norman M. , Mazur A. , Gruskin A. , Rasmussen H. Bone marrow histomorphometry in children with early chronic renal failure treated with 25(OH)D₃. In Vitamin D. Basic research and its clinical application. Berlin, waiter de Gruyter & Co, 1979; p. 847.

Chesney R.W. , Dabbagh S. , Uehling D.T. , DeLuca H.F. The importance of early treatment of renal bone disease in children. Kidney Int, in press.